What is Immunome's AOCI?

Immunome (IMNM) reported AOCI of $0 in Q4 2025.

How has Immunome's AOCI changed year-over-year?

Immunome's AOCI decreased by 100.0% year-over-year, from $57K to $0.

What is the long-term trend for Immunome's AOCI?

Over 2 years (2023 to 2025), Immunome's AOCI has grown at a -100.0% compound annual growth rate (CAGR), from $22K to $0.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Immunome IMNM AOCI

AOCI at other companies

PfizerPFE

-$7.2B+16.1%

Arcus BiosciencesRCUS

-$1M—

Nuvation BioNUVB

-$1.68M-408%

ArriVent BioPharma, Inc.AVBP

-$270K-1,488%

IDEAYA Biosciences, Inc.IDYA

-$494K-131%

ImmunityBio, Inc.IBRX

$27.45M+37.6%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Immunome’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's AOCI?: Immunome (IMNM) reported AOCI of $0 in Q4 2025.
How has Immunome's AOCI changed year-over-year?: Immunome's AOCI decreased by 100.0% year-over-year, from $57K to $0.
What is the long-term trend for Immunome's AOCI?: Over 2 years (2023 to 2025), Immunome's AOCI has grown at a -100.0% compound annual growth rate (CAGR), from $22K to $0.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.